Cell Phone Location Used to Estimate COVID-19 Growth Rates

PHILADELPHIA — New research shows that counties with a greater decline in workplace cell phone activity during stay-at-home orders showed a lower rate of COVID-19 infections. The researchers believe patterns they saw in publicly available cell phone location data could be used to better estimate COVID-19 growth rates and inform decision-making when it comes to shutdowns and “reopenings.” This research was published today in JAMA Internal Medicine.

              “It is our hope that counties might be able to incorporate these publicly available cell phone data to help guide policies regarding re-opening throughout different stages of the pandemic,” said the study’s senior author, Joshua Baker, MD, MSCE, an assistant professor of Medicine and Epidemiology. “Further, this analysis supports the incorporation of anonymized cell phone location data into modeling strategies to predict at-risk counties across the U.S. before outbreaks become too great.”

              Baker and the other researchers, including the study’s lead author Shiv T. Sehra, MD, an assistant professor of Medicine at the Harvard Medical School, used location data from cell phones – which were de-identified and made publicly available by Google – to analyze activity across up to 2,740 counties in the United States between early January and early May 2020. This data was broken up into locations where the activity took place, ranging from workplaces, to homes, retail stores, grocery stores, parks, and transit stations. Roughly between 22,000 and 84,000 points of data were analyzed for each day in the study period.

              The idea was to compare where cell phone activity took place as a proxy to show where people, themselves, spent their time. This data was compared between two time periods: the first in January and February, before COVID-19’s outbreak in the United States, then mid-February through early May, during the virus’ initial surges and when stay-at-home orders were enacted.

              Intuitively, they noted an increase in time spent at home, while visits to the workplace dropped significantly, along with a decline in visits to retail locations (such as stores and restaurants) and transit stations.

They saw that in counties where there was initially a higher density of cases, visits to  workplaces, as well as retail locations and transit stations, fell more sharply than counties less affected by COVID-19. At the same time, in these counties, there was a more prominent spike  in activity at homes.

              In addition, the researchers saw that the counties where workplace activity fell the most had the lowest rates of new COVID-19 cases in the days that followed. Lag-times of 5, 10 and 15 days were observed to allow time for COVID-19’s incubation period, but the lower infection rates held across the range.

              Moving forward, Baker hopes more work can be done to vet cell phone data to see if they can be specifically used to predict COVID-19 hotspots and guide decision-making.

              “It will be important to confirm that cell phone data is useful in other stages of the pandemic beyond initial containment,” Baker said. “For example, is monitoring these data helpful during the reopening phases of the pandemic, or during an outbreak?”

              Past its immediate importance for COVID-19, Baker sees future utility for this type of data.

              “They do have the potential to help us better understand behavioral patterns which could help future investigators predict the course of future epidemics or perhaps monitor the impact of different public health measures on peoples’ behaviors,” he said.

              This research was funded partly by a Veterans Affairs Clinical Science Research & Development Merit Award (I01 CX001703).

Michael George, MD, Douglas Wiebe, PhD, and Shelby Fundin, all of Penn, were co-authors on this study.

###

Penn Medicine is one of the world’s leading academic medical centers, dedicated to the related missions of medical education, biomedical research, and excellence in patient care. Penn Medicine consists of the Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania (founded in 1765 as the nation’s first medical school) and the University of Pennsylvania Health System, which together form a $8.6 billion enterprise.

The Perelman School of Medicine has been ranked among the top medical schools in the United States for more than 20 years, according to U.S. News & World Report’s survey of research-oriented medical schools. The School is consistently among the nation’s top recipients of funding from the National Institutes of Health, with $494 million awarded in the 2019 fiscal year.

The University of Pennsylvania Health System’s patient care facilities include: the Hospital of the University of Pennsylvania and Penn Presbyterian Medical Center—which are recognized as one of the nation’s top “Honor Roll” hospitals by U.S. News & World Report—Chester County Hospital; Lancaster General Health; Penn Medicine Princeton Health; and Pennsylvania Hospital, the nation’s first hospital, founded in 1751. Additional facilities and enterprises include Good Shepherd Penn Partners, Penn Medicine at Home, Lancaster Behavioral Health Hospital, and Princeton House Behavioral Health, among others.

Penn Medicine is powered by a talented and dedicated workforce of more than 43,900 people. The organization also has alliances with top community health systems across both Southeastern Pennsylvania and Southern New Jersey, creating more options for patients no matter where they live.

Penn Medicine is committed to improving lives and health through a variety of community-based programs and activities. In fiscal year 2019, Penn Medicine provided more than $583 million to benefit our community.